Yahoo! Finance: Biotechnology Industry News: NW Bio Announces Above-Market Conversion of its $11.6 Million Debt to Its Manufacturer, Cognate Bioservices

Yahoo! Finance: Biotechnology Industry News The latest news on the Biotechnology industry from Yahoo! Finance

NW Bio Announces Above-Market Conversion of its $11.6 Million Debt to Its Manufacturer, Cognate Bioservices Jul 31st 2013, 12:15 [PR Newswire] - BETHESDA, M.D., July 31, 2013 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO)(NW Bio), a biotechnology company developing non-toxic DCVax ® personalized immune therapies for solid tumor cancers, ...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions